PMI Impact Malaria

Project
Overview

PMI Impact Malaria was the U.S. President’s Malaria Initiative’s (PMI) flagship global malaria service delivery project from February 2018-May 2024, funded and technically assisted by PMI and led PSI in partnership with Jhpiego, MCD Global Health, and the Malaria Elimination Institute (MEI) at the University of California San Francisco. PMI Impact Malaria supported national malaria programs to fight malaria and save lives by strengthening diagnosis, treatment, and drug-based prevention for those most at risk, particularly children and pregnant women.

We supported national malaria programs to advance malaria service delivery by working to:

Close the gaps in malaria diagnosis and treatment to get the right medicine, with the correct diagnosis, to patients in need, in the timeliest manner.

Unlock the potential of drug-based malaria prevention approaches by helping countries introduce, implement, and scale-up proven interventions.

Improve malaria health systems and data for decision-making through developing and disseminating technical learning and evidence.

PMI Impact Malaria accomplished its mandate by strengthening the capacity of National Malaria Programs, regional and district health authorities, health facility staff, and community health workers to deliver these services, manage quality improvement programs, and collect and use high-quality data to monitor and refine those programs.   

Where
We worked

PMI Impact Malaria worked in 19 countries and had two regional buy-ins, in Latin America and the Caribbean and sub-Saharan Africa. Explore the interactive map to see where PMI Impact Malaria worked.

Bénin
Burkina Faso
Burma
Cambodia
Cameroun
Côte d’Ivoire
DR Congo
Ghana
Kenya
Laos
Madagascar
Senegal
Sierra Leone
Tanzania
Zambia
Malawi
Mali
Niger
Rwanda

Six Years of Impact

More than 84 million

doses of prevention medicine provided to children through seasonal malaria chemoprevention campaigns.

11,959 OTSS Visits

to 4,700 health facilities and 4,663 health workers trained with the most up-to-date global and national guidelines

18,198 CHWs

recruited and trained in integrated community case management service interventions

1,761,988 children

receiving fever care by trained CHWS.

7 countries

recorded increased rates of medicine uptake to prevent malaria in pregnancy

14 therapeutic efficacy studies

conducted at 40 study sites across 10 countries.

18 e-learning modules developed

on quality improvement, case management, malaria in pregnancy and to improve access to health worker trainings during the COVID-19 pandemic

How we
worked

PMI Impact Malaria supported national malaria programs in partner countries to strengthen the quality of and access to malaria case management and prevention of malaria in pregnancy, improve the quality of and access to malaria drug-based approaches, and provide global technical leadership and support for operational research. PMI’s Outreach, Training, and Supportive Supervision (OTSS) quality improvement model underpinned our support for national capacity strengthening at the health facility and individual health provider levels. We supported activities and interventions in eight focus areas: